2019 Press Releases


Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015
January 6, 2019
Xenon Pharmaceuticals Outlines 2019 Key Milestones
Innovative Product Pipeline Includes Multiple Neurology-Focused Products Anticipated to be in Phase 2 or Later Stage Development in 2019 BURNABY, British Columbia, Jan. 06, 2019 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today provide... More >>